ARTICLES BY THIS AUTHOR
- 10/4/2021
Canada's changing pharmacy landscape
Rising banners reflect the new reality of exciting new pharmacy practice opportunities - 10/4/2021
5 Tips: Twitter for pharmacists
With an estimated 350 million monthly users, Twitter is one of the most influential and divisive social media platforms of the 21st century - 10/4/2021
Wholehealth’s 100th store is a first in Canada!
Insalata Cannabis Market is the first recreational cannabis store to have two licensed pharmacists who specialize in cannabis, as business partners. They are now the guiding force for helping Wholehealth pharmacists and technicians manage patient questions. - 10/3/2021
Advil Cold & Sinus day/night blister packs recalled due to labelling error
Health Canada says mistakenly taking a nighttime caplet could result in serious health consequences for those who need to remain alert. - 10/3/2021
Non-melanoma skin cancer rates up 30% in Ontario from 2003 to 2017
While most deaths occurred in adults older than age 65, the study found the annual incidence rate of new cases was highest in people younger than 35. - 9/30/2021
Fighting cancer better with AI
Canadian, American, German and Belgian researchers have developed an artificial intelligence application that has been able to collect and then synthesize for analysis millions of medical data concerning cancer patients followed for a decade. - 9/30/2021
Merck says experimental pill cuts worst effects of COVID-19
If cleared, the drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. - 9/30/2021
Spotlight 7: Massage therapist blessings
A patient who kept on wanting massage therapy for his chronic anxiety but wouldn’t consider meds or psychotherapy. That didn’t thrill Dr. Jassam—but then the patient’s requests went to something he had to say no to. - 9/30/2021
Drug combo yields ‘excellent’ survival outcomes in HER2+/HR- early breast cancer
Pertuzumab and trastuzumab plus paclitaxel strong survival outcomes in HER2+/HR- early breast cancer. Results from the WSG (West German Study Group)-ADAPT Her2+/HR- trial at the 2021 ASCO conference.